Food and Drug Administration announced it will take enforcement action against non-FDA-approved compounded GLP-1 drugs that are being mass-marketed as alternatives to FDA-approved therapies
Weight, Heart, and Practical Expectations Xigduo weight loss is usually modest when it occurs
Social divides persist: 73% of women and 61% of men feel pressure to lose weight
They have company registrations dating back multiple years with business scopes including pharmaceutical or chemical manufacturing
Metabolic Function Research Retas influence on glucose tolerance, insulin sensitivity, and lipid metabolism makes it a useful tool for exploring the hormonal and cellular pathways tied to type 2 diabetes, insulin resistance, and non-alcoholic fatty liver disease (NAFLD)
The trial enrolled 338 participants across four dose groups plus placebo and ran for 48 weeks